Cefdiren 400 Tablet
Cefditoren
400mg
Ibn Sina Pharmaceutical Ind. Ltd.
| Pack size | 8's Pack |
|---|---|
| Retail Price | 250.00 |
Indications
Pharyngitis, Community-acquired pneumonia, Susceptible infections, Tonsillitis, Soft tissue infections, Respiratory tract infections, Acute Exacerbations of Chronic bronchitis
Adult Dose
Oral
Community-acquired pneumonia
Adult: 400 mg bid for 14 days.
Acute bacterial exacerbation of chronic bronchitis
Adult: 400 mg bid for 10 days.
Pharyngitis ; Tonsillitis; Uncomplicated skin and skin structure infections
Adult: 200 mg bid for 10 days.
Child Dose
<12 years old: Safety & efficacy not established
>12 years old: As in adults
Renal Dose
Renal Impairment
CrCl 30-49 mL/minute/1.73 sq. meter: No more than 200 mg PO q12hr
CrCl <30 mL/minute/1.73/sq.meter: 200 mg PO qDay
End-stage: Dosing not established
Administration
Should be taken with food.
Contra Indications
Hypersensitivity to Cefditoren, other cephalosporins; or milk proteins. Carnitine deficiency.
Precautions
May cause diarrhea, nausea, and vaginal moniliasis (yeast infection); pseudomembranous colitis may occur; clinical manifestations of carnitine deficiency may occur with prolonged use; prolonged use may result in emergence and overgrowth of resistant organisms; caution in breastfeeding
Pregnancy-Lactation
B
Pregnancy Category: B
Lactation: excretion in milk unknown; use with caution
Interactions
Reduced oral bioavailability when coadministered with antacids or H2-receptor antagonists.
Probenecid may increase plasma concentration and prolong the half-life of Cefditoren.
May enhance the anticoagulant effect of vitamin K antagonists (e.g. warfarin).
Contraindicated (0)
Serious (3)
BCG vaccine live
cholera vaccine
microbiota oral
Adverse Effects
>10%
Diarrhea (11-15%)
1-10%
Nausea (4-6%),Headache (2-3%),Abdominal pain (2%),Dyspepsia (1-2%),Vomiting (1%)
<1%
Bacterial/fungal superinfection,C. difficile colitis,Hypersensitivity,Increased bleeding time,Stevens-Johnson syndrome,Vaginal moniliasis
Potentially Fatal: Hypersensitivity, anaphylaxis, Stevens-Johnson syndrome, toxic epidermal necrolysis.
Mechanism of Action
Cefditoren is a third generation cephalosporin used for treatment of susceptible infections caused by gram-positive and gram-negative bacteria. It inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins (PBPs).
Note
Cefdiren 400 400mg Tablet manufactured by Ibn Sina Pharmaceutical Ind. Ltd.. Its generic name is Cefditoren.